Circulation Population Health and Outcomes·30 AugLipoprotein (a) Testing and Changes in Lipid-Lowering Therapy in Patients With ASCVD: Findings From the cvMOBIUS-2 RegistryStudy in peoplePopulationsPaper
JACC Advances·22 AugEvent-Driven Intensification and Persistent Therapeutic Inertia in LDL-C Management Among 1,033,703 Patients With ASCVDStudy in peoplePopulationsPaper
AHA Scientific Sessions 2025 Abstract·3 NovReal World Evaluation of the Eligibility, Uptake, and Cardiometabolic Effects of Tirzepatide: An Analysis from the Platform for Evidence GeneraTion in CArdiometabolic HeaLth (PETAL) StudyStudy in peoplePopulationsPaper
AHA Scientific Sessions 2025 Abstract·3 NovLongitudinal LDL-C Control Among Patients With ASCVD and Elevated Baseline LDL-C: Insights From the cvMOBIUS-2 RegistryStudy in peoplePopulationsPaper